Bisoprolol Fumarate and Hydrochlorothiazide
- Product NDC
- 50090-5905
- Requested package NDC
- 50090-5905-0
- 11-digit product format
- 500905905
- Labeler code
- 50090
- Product ID
- 50090-5905_fe02e259-324e-4cee-9151-6c4711e2b507
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bisoprolol Fumarate and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA212678
- Marketing category
- ANDA
- Marketing start
- 2019-04-30
- Substance
- BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
- Active strength
- 10; 6.25 mg/1; mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | |
| A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | |
| A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212678-001 | AB |
| A212678-002 | AB |
| A212678-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212678-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212678-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212678-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2020-07-09 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212678-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212678-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212678-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212678-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212678-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212678-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212678-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212678-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212678-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212678-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212678-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212678-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212678-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212678-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212678-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212678-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212678-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212678-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212678-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212678-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212678-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212678-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212678-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212678-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212678-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212678-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212678-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212678-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212678-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212678-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212678-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212678-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212678-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A212678-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A212678-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A212678-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212678-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212678-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212678-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212678-001 | AB | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bisoprolol Fumarate and Hydrochlorothiazide
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BISOPROLOL FUMARATE | 10 mg/1 |
| HYDROCHLOROTHIAZIDE | 6.25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| UR59KN573L | Internal UNII lookup |
| 0J48LPH2TH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 854908 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6b7f96c3-daf4-4029-a96b-baa37add0edb | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-5905-0 | 2025-09-05 | C162847 | 48780-1 | 1030e365-38a0-111a-e063-dadaa90a10e2 | Bisoprolol Fumarate and Hydrochlorothiazide Tablets |
| 50090-5905-0 | 2024-01-30 | C162847 | 48780-1 | 1030e365-38a0-111a-e063-dadaa90a10e2 | Bisoprolol Fumarate and Hydrochlorothiazide Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5905-0 | Bisoprolol Fumarate and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5905-0 | EA - Each | 50090-5905 | 0e4425cd-a81f-47a4-963f-ab4244d5795b | 1 | 2022-06-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5905 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220121_6b7f96c3-daf4-4029-a96b-baa37add0edb.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Edenbridge Pharmaceuticals LLC. | 295532b5-65c8-40c3-8d27-cfd334d12802 | 2026-08-28 | Warnings, Adverse reactions | 212678 ANDA212678 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 53221419-204c-40a2-9ec3-8e4b994dd39d | 2026-08-20 | Warnings, Adverse reactions | 212678 ANDA212678 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 12ba7eba-1874-41b6-aff5-7baba8b99984 | 2026-08-20 | Warnings, Adverse reactions | 212678 ANDA212678 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 154cb1d2-9fb2-4c8d-90de-6a8062a8d1ba | 2026-08-19 | Warnings, Adverse reactions | 212678 ANDA212678 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 6b7f96c3-daf4-4029-a96b-baa37add0edb | 2025-09-05 | Warnings, Adverse reactions | 212678 ANDA212678 50090-5905-0 50090-5905 50090590500 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 854908 | bisoprolol fumarate 10 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet | PSN | 6b7f96c3-daf4-4029-a96b-baa37add0edb | 3 |
| 854908 | bisoprolol fumarate 10 MG / hydrochlorothiazide 6.25 MG Oral Tablet | SCD | 6b7f96c3-daf4-4029-a96b-baa37add0edb | 3 |
| 854908 | bisoprolol fumarate 10 MG / HCTZ 6.25 MG Oral Tablet | SY | 6b7f96c3-daf4-4029-a96b-baa37add0edb | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-5905-0 | 50090590500 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5905-0) | 2022-01-17 | 0000-00-00 | No | No | Current |